Association of monocyte tumor necrosis factor α expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease

Journal of Vascular Surgery

Volumn 61, Issue 1, 2015, Pages 155-161

  Pande, Reena L ^a   Brown, Jonathan ^a   Buck, Stewart ^a   Redline, Whitney ^a   Doyle, Jeanne ^a   Plutzky, Jorge ^a   Creager, Mark A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENDER; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INFLAMMATION; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL PERFORMANCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAL TIME POLYMERASE CHAIN REACTION; SMOKING; TREADMILL TEST; VERY ELDERLY; WALKING; WALKING DIFFICULTY; WALKING TIME; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; EXERCISE TEST; EXERCISE TOLERANCE; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; MONOCYTES; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WALKING;

EID: 84919431101     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.06.116     Document Type: Article

References (33)

1. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; Transatlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 654
2. R.L. Pande, W.R. Hiatt, P. Zhang, N. Hittel, and M.A. Creager A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication Vasc Med 15 2010 181 188
3. A.D. Pradhan, N. Rifai, and P.M. Ridker Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men Circulation 106 2002 820 825
4. A.D. Pradhan, S. Shrivastava, N.R. Cook, N. Rifai, M.A. Creager, and P.M. Ridker Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk Circulation 117 2008 823 831
5. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease Circulation 97 1998 425 428
6. P.M. Ridker, M.J. Stampfer, and N. Rifai Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease JAMA 285 2001 2481 2485
7. C.D. Owens, P.M. Ridker, M. Belkin, A.D. Hamdan, F. Pomposelli, and F. Logerfo Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery J Vasc Surg 45 2007 2 9
8. J.A. Beckman, O. Preis, P.M. Ridker, and M. Gerhard-Herman Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death) Am J Cardiol 96 2005 1374 1378
9. H. Vidula, L. Tian, K. Liu, M.H. Criqui, L. Ferrucci, and W.H. Pearce Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study Ann Intern Med 148 2008 85 93
10. M.M. McDermott, P. Greenland, D. Green, J.M. Guralnik, M.H. Criqui, and K. Liu D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease Circulation 107 2003 3191 3198
11. E.R. Mohler III, W.R. Hiatt, and M.A. Creager Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease Circulation 108 2003 1481 1486
12. S. Mondillo, P. Ballo, R. Barbati, F. Guerrini, T. Ammaturo, and E. Agricola Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease Am J Med 114 2003 359 364
13. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
14. G. Brevetti, A. Silvestro, S. Di Giacomo, R. Bucur, A. Di Donato, and V. Schiano Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden J Vasc Surg 38 2003 374 379
15. R.L. Pande, T.S. Perlstein, J.A. Beckman, and M.A. Creager Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004 Circulation 118 2008 33 41
16. A.L. Hevener, J.M. Olefsky, D. Reichart, M.T. Nguyen, G. Bandyopadyhay, and H.Y. Leung Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones J Clin Invest 117 2007 1658 1669
17. S.S. Signorelli, M.C. Mazzarino, L. Di Pino, G. Malaponte, C. Porto, and G. Pennisi High circulating levels of cytokines (IL-6 and TNFα), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test Vasc Med 8 2003 15 19
18. G.M. Andreozzi, R. Martini, R. Cordova, A. D'Eri, G. Salmistraro, and M. Mussap Circulating levels of cytokines (IL-6 and IL-1β) in patients with intermittent claudication, at rest, after maximal exercise treadmill test and during restore phase. Could they be progression markers of the disease? Int Angiol 26 2007 245 252
19. A.T. Edwards, A.D. Blann, V.J. Suarez-Mendez, A.M. Lardi, and C.N. McCollum Systemic responses in patients with intermittent claudication after treadmill exercise Br J Surg 81 1994 1738 1741
20. F.J. Neumann, W. Waas, C. Diehm, T. Weiss, H.M. Haupt, and R. Zimmermann Activation and decreased deformability of neutrophils after intermittent claudication Circulation 82 1990 922 929
21. G. Brevetti, F. Piscione, P. Cirillo, G. Galasso, V. Schiano, and E. Barbato In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction Atherosclerosis 201 2008 440 446
22. S.J. Nicholls, and S.L. Hazen Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 2005 1102 1111
23. W.S. Aronow, D. Nayak, S. Woodworth, and C. Ahn Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment Am J Cardiol 92 2003 711 712
24. U. Bregar, P. Poredos, M. Sabovic, B. Jug, and M. Sebestjen The influence of atorvastatin on walking performance in peripheral arterial disease Vasa 38 2009 155 159
25. W.R. Hiatt, A.T. Hirsch, M.A. Creager, S. Rajagopalan, E.R. Mohler, and C.M. Ballantyne Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease Vasc Med 15 2010 171 179
26. L.L. Craft, J.M. Guralnik, L. Ferrucci, K. Liu, L. Tian, and M.H. Criqui Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease Am J Cardiol 102 2008 1263 1268
27. A.C. Alibegovic, M.P. Sonne, L. Hojbjerre, J. Bork-Jensen, S. Jacobsen, and E. Nilsson Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men Am J Physiol Endocrinol Metab 299 2010 E752 E763
28. M.C. Venables, and A.E. Jeukendrup Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus Diabetes Metab Res Rev 25 Suppl 1 2009 S18 23
29. N.M. Hamburg, C.J. McMackin, A.L. Huang, S.M. Shenouda, M.E. Widlansky, and E. Schulz Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers Arterioscler Thromb Vasc Biol 27 2007 2650 2656
30. G. Brevetti, G. Giugliano, L. Brevetti, and W.R. Hiatt Inflammation in peripheral artery disease Circulation 122 2010 1862 1875
31. R.P. Wildman, P. Muntner, J. Chen, K. Sutton-Tyrrell, and J. He Relation of inflammation to peripheral arterial disease in the National Health and Nutrition Examination Survey, 1999-2002 Am J Cardiol 96 2005 1579 1583
32. M.M. McDermott, L. Ferrucci, J.M. Guralnik, L. Tian, D. Green, and K. Liu Elevated levels of inflammation, D-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease J Am Coll Cardiol 50 2007 897 905
33. M. Visser, M. Pahor, D.R. Taaffe, B.H. Goodpaster, E.M. Simonsick, and A.B. Newman Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: The Health ABC Study J Gerontol A Biol Sci Med Sci 57 2002 M326 M332